HCV treatment--no more room for interferonologists?

N Engl J Med. 2013 May 16;368(20):1931-2. doi: 10.1056/NEJMe1303818. Epub 2013 Apr 23.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Female
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / therapeutic use*
  • Male
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Ribavirin / therapeutic use*
  • Sofosbuvir
  • Uridine Monophosphate / analogs & derivatives*
  • Uridine Monophosphate / therapeutic use
  • Viral Nonstructural Proteins / antagonists & inhibitors*

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Recombinant Proteins
  • Viral Nonstructural Proteins
  • Polyethylene Glycols
  • Ribavirin
  • Uridine Monophosphate
  • peginterferon alfa-2a
  • Sofosbuvir